Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism-Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04994080
What this trial is testing

Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
Chengdu Suncadia Medicine Co., Ltd. 84
Post-approval studies (Phase 4)Study completedNCT00528788
What this trial is testing

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Who this might be right for
Hyperparathyroidism, SecondaryKidney Failure, Chronic
Duke University 24
Not applicableUnknownNCT04515342
What this trial is testing

Sarcopenia, Fall and Osteoporosis in Chronic Kidney Disease

Who this might be right for
SarcopeniaChronic Kidney DiseasesOsteoporosis
Herlev Hospital 140
Not applicableLooking for participantsNCT05242055
What this trial is testing

Integrated Diagnosis and Treatment of CKD on Outcomes

Who this might be right for
Chronic Kidney DiseasesHypertensionHyperglycemia+4 more
Capital Medical University 1,000
Not applicableUnknownNCT01382966
What this trial is testing

Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients

Who this might be right for
Chronic Kidney DiseaseRenal OsteodystrophyLeft Ventricular Hypertrophy
RFM Renal Treatment Services 400
Not applicableStudy completedNCT00285467
What this trial is testing

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

Who this might be right for
Renal Osteodystrophy
Indiana University 55
Not applicableLooking for participantsNCT06126016
What this trial is testing

A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

Who this might be right for
Chronic Kidney Disease 5DSecondary Hyperparathyroidism
Boryung Pharmaceutical Co., Ltd 1,000
Large-scale testing (Phase 3)Study completedNCT01341782
What this trial is testing

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismHemodialysis
AbbVie (prior sponsor, Abbott) 255
Testing effectiveness (Phase 2)Study completedNCT00667576
What this trial is testing

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

Who this might be right for
Chronic Kidney Disease on HemodialysisSecondary Hyperparathyroidism
Abbott 153
Not applicableStudy completedNCT06314321
What this trial is testing

The Effect of Baduanjin on Shoulder Function in Maintenance Hemodialysis Patients

Who this might be right for
Hemodialysis ComplicationShoulder Joint DisorderCKD-MBD
Affiliated Hospital of Nantong University 60
Post-approval studies (Phase 4)Study completedNCT01675089
What this trial is testing

Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation

Who this might be right for
Renal Osteodystrophy
University of Sao Paulo General Hospital 34
Not applicableStudy completedNCT00800358
What this trial is testing

Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism

Who this might be right for
HyperparathyroidismKidney Disease
Penang Hospital, Malaysia 69
Not applicableActive Not RecruitingNCT07685223
What this trial is testing

Medium Cut-Off and High-Flux Membranes on Mineral and Bone Metabolism in Hemodialysis Patients

Who this might be right for
End Stage Kidney Disease (ESKD)HemodialysisChronic Kidney Disease Mineral and Bone Disorder
Gazi University 30
Not applicableStudy completedNCT01368042
What this trial is testing

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 265
Large-scale testing (Phase 3)Study completedNCT01382212
What this trial is testing

Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis

Who this might be right for
End-Stage Renal DiseaseSecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 13
Not applicableStudy completedNCT05399251
What this trial is testing

Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Aga Khan University Hospital, Pakistan 1,553
Not applicableStudy completedNCT00995163
What this trial is testing

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease

Who this might be right for
End Stage Renal DiseaseHyperparathyroidism, Secondary
Kyowa Kirin Co., Ltd. 8,020
Early research (Phase 1)Study completedNCT01167309
What this trial is testing

LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

Who this might be right for
Secondary Hyperparathyroidism
LEO Pharma 72
Post-approval studies (Phase 4)Study completedNCT03588884
What this trial is testing

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesVitamin D InsufficiencyCKD Stage 3+1 more
OPKO Health, Inc. 69
Not applicableStudy completedNCT01081665
What this trial is testing

Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney FailureSecondary Hyperparathyroidism
Abbott 237
Next Page